Home > PJ > News / Daily News

Return to PJ Online Home Page
The Pharmaceutical Journal Vol 266 No 7151 p770-772
June 9, 2001

News summary

Two-year discharge intervention trial running in East Anglia Pharmacists in Norfolk and Suffolk are taking part in a discharge intervention trial designed to find out if the hospital readmission rate for older people can be cut by better control of their medication...[more]

Applications to study pharmacy fall Applications to study pharmacy at United Kingdom universities have fallen by 12.9 per cent...[more]

Leeds teaching hospitals contract Pharmacy2U to deliver medicines The Leeds Teaching Hospitals NHS trust has given the Pharmacy2U online pharmacy company a two-year contract to supply medicines...[more]

Volunteers wanted for Neema project The International Pharmaceutical Students Federation is now looking for volunteer pharmacy students to work at a dispensary its has built in Tanzania...[more]

EHC controversy in Spain The launch of levonorgestrel in Spain as an emergency contraceptive has provoked controversy in the country, with complaints that the price is excessive and ethical objections from some pharmacists...[more]

Asda launches diabetes initiative Asda Pharmacy is to run an in-store disease-led marketing campaign during diabetes week (June 10 to 16)...[more]

Boots increases emphasis on health and beauty Boots The Chemists Ltd plans to boost sales of health and beauty products and services through its stores with new retail formats, including an upmarket Pure Beauty concept...[more]

Wholesalers to continue European expansion Alliance Unichem Plc and Gehe AG have continued their European expansion drives with further acquisitions in Italy and Norway...[more]

Roche to shut UK R&D site F Hoffman-La Roche Ltd is to close its pharmaceutical research and development and manufacturing operations at Welwyn Garden City, Hertfordshire, with the loss of around 700 jobs...[more]

SSL forced to restate profits SSL International Plc, owner of the Durex, Scholl and Regent Biogel brands, has been forced to restate its trading figures for 2000 after an investigation found that both sales and profits had been overstated because of advance purchasing by customers...[more]

NEWS IN BRIEF

Homoeopathic prospectus The Faculty of Homoeopathy has issued a prospectus of postgraduate courses for health professionals for 2001–02. Included are details of an advanced course for pharmacists leading to a diploma qualification — DFHom (Pharm). Calls from members of the public to the faculty about homoeopathy have doubled, from 400 to 800 a month, in the past year. June 14–21 is Homoeopathy Awareness Week.

Homoeopathic consultation line A telephone consultation service for homoeopathic inquiries is to be launched in September. Consultations will cost up to £10 through a £1.50 per minute premium rate call. Grassroots Homoeopathy and Stream Group Plc expect that pharmacies which make a telephone available to customers will generate increased sales of homoeopathic remedies.



Two-year discharge intervention trial running in East Anglia

Pharmacists in Norfolk and Suffolk are taking part in a discharge intervention trial designed to find out if the hospital readmission rate for older people can be cut by better control of their medication. The study is expected to last for two years and is to involve over 600 people aged 80 years and over.

The principal investigator, Dr Richard Holland, of the University of East Anglia’s school of health policy and practice, said: “We want to see whether home visits by pharmacists who can advise and help deal with any problems make a difference. We believe it could improve older people’s health and prevent them going back into hospital.”

People who are discharged from hospital to their own homes and who are taking two or more medicines are eligible for the trial. Half of them will receive two home visits from a pharmacist — one within five days of discharge and the second six to eight weeks later. Twenty-one pharmacists have been trained for the project. They will carry out full medication reviews before they see each patient.

During the visits they will assess each patient’s understanding of all their medicines, including any over-the-counter medicines they may be taking, and whether they need any specific help. This could include reminder charts, larger bottles that are easier to open, non-child resistant closures, larger labels or a compliance aid. If compliance aids are needed, the trial has the funds to provide these along with fees payable to the dispensing pharmacists for six months. Feedback about the patient is provided to the relevant community pharmacist and family doctor.

Six months later, the research team will assess the patient’s quality of life according to the EuroQol standard (information about which can be found on the internet and any hospital admissions.

Dr Holland says that no interim results of the project will be available because no analysis is to be made until the project is completed next year.

The trial is being conducted with patients discharged from the Norfolk and Norwich, James Paget and Ipswich hospitals.

Back to Top


Applications to study pharmacy fall

Applications to study pharmacy at United Kingdom universities have fallen by 12.9 per cent.

A total of 14,875 applications to study pharmacy were made this year, representing over 7 for each of the 2,000 places available. The actual number of pharmacy applicants is much lower because the figures include multiple students’ multiple applications to more than one institution.

The decline in applications for a pharmacy degree, which remains a popular course, stands in stark contrast to an 11.5 per cent increase in applications to train as nurses.

Other popular subjects include computer science (up 11.1 per cent), humanities with arts (up 10.2 per cent), physical sciences (up 12.3 per cent) and medical subjects other than preclinical medicine, dentistry and veterinary science (down 11.9 per cent).

Applications to study dentistry were down by 27.5 per cent and veterinary applications by 26.8 per cent. Preclinical medicine applications fell by 1.1 per cent.

Back to Top


Leeds teaching hospitals contract Pharmacy2U to deliver medicines

The Leeds Teaching Hospitals NHS trust has given the Pharmacy2U online pharmacy company a two-year contract to supply medicines.

Pharmacy2U won the contract after a tendering exercise and will deliver medicines to a number of points within the trust and also to patients’ homes. The service is currently concentrated on two clinical areas — renal and HIV therapy — but may be expanded. Medicines for outpatients are to be delivered to their homes, their places of work or any location chosen by them.

The trust and Pharmacy2U are also to develop an electronic prescribing link from the hospital to the online pharmacy. There is also a possibility that the dispensing service will be extended to include discharge medication.

The two organisations say that they have five partnership aims

  1. To work together to ensure that clinical pharmacy time is spent at ward level where it is most needed
  2. To reduce outpatient waiting times and pressure in the hospital by delivering medicines to patients’ homes
  3. To reduce costs through flexible home care arrangements
  4. To provide additional reporting information
  5. To develop electronic prescribing links

Jon Cohen, Pharmacy2U’s professional services director, says that the advantages of this sort of working arrangement are clear — retaining clinical pharmacists at ward level as well as relieving pressure on hospital dispensaries and clinical budgets.

Pharmacy2U was one of Britain’s first online pharmacy companies. It currently sells general sale list and pharmacy medicines and dispenses private prescriptions over the internet. It is also part of one of three consortia to win contracts to pilot the electronic transfer of NHS prescriptions.

A hospital spokeswoman said that the work involved would otherwise have been done by technicians.

Back to Top


Volunteers wanted for Neema project

The International Pharmaceutical Students Federation is now looking for volunteer pharmacy students to work at a dispensary its has built in Tanzania.

The first four students, from Canada, are already in place and the next four have been recruited. Applications for the third rotation close at the end of June. In addition to the volunteer students, the dispensary is to be stafffed by a pharmacy assistant, two nurses and a medical assistant.

Eight years after its inception, the dispensary provided by the International Pharmaceutical Students Federation’s Neema project has been declared open.

The opening ceremony was performed on May 27 by the Tanzanian deputy minister of health, Dr Hussain Mwinyi. A pharmacy and pharmacy store, together with a laboratory and a mother and child health care centre, including delivery and recovery rooms, have been built to serve the three Tanzanian villages of Kiromo, Buma and Mataya — a total population of 7,279 people including 1,276 children under five years old. There is currently no electricity, although an electricity cable runs nearby.

The funds to build the facility have been raised through the efforts of pharmacy students world-wide, including members of the British Pharmaceutical Students Association. The total cost will be about $100,000.

In Tanzania, a dispensary is more than a place where medicines are dispensed; it is a one-stop primary care post offering medical advice on all sorts of problems from diarrhoea to complicated labour.

Before the dispensary was opened, up to 70 per cent of deaths in Kiromo were caused by malaria or preventable childhood diseases, 30 per cent of deaths were directly attributable to a lack of sanitation and 29 per cent to the non-availability of medicines. The next nearest dispensary is 10km away.

The project was conceived in 1993 by Winna Shango, a local Tanzanian student. It took off in 1997 at the IPSF congress in Vancouver, Canada, when the Canadian Association of Pharmacy Students and Interns and the American Pharmaceutical Association-Academy of Student Pharmacists became partners. In 1998, the British Pharmaceutical Students Association became the third international partner. These organisations, and the Commonwealth Pharmaceutical Association then raised the funds for the project.

The overall aim was to build the dispensary, as well as separate living quarters for staff. When fully operational, it will have a staff of four — a pharmacy assistant, two nurses and a medical assistant. For the first three years, IPSF students and students from the local university at Dar es Salaam will work in the dispensary for periods of from three to six months. After this, the local government will take over the running of the dispensary as a sustainable facility. Much of the medicines will be provided by the generosity of companies in East Africa.

The project is to be fully evaluated, with an initial base-line survey and a detailed three-year survey to measure its outcomes. Neema is a Swahili word meaning “grace”.

More information about the project and how to become involved is available on the internet at www.ipsf.org.

Back to Top


EHC controversy in Spain

The launch of levonorgestrel in Spain as an emergency contraceptive has provoked controversy in the country, with complaints that the price is excessive and ethical objections from some pharmacists.

There was widespread acclaim when the product was approved in March, but this changed when health minister Celia Villalobos announced that the state health service would not pay for the treatment. Instead, people would have to buy it using private prescriptions. On May 9, Ms Villalobos ruled out the possibility that the state health system was going to pay for the drug, saying that it was not a priority issue, given the country’s huge drugs bill.

But taking advantage of its local powers concerning health, on May 15 the Andalusian regional government made the product available free of charge and without prescription to women who requested it following unprotected intercourse. Free availability did not extend to pharmacies. The Andalusian health department also ruled that all pharmacies must supply levonorgestrel when requested by prescription.

The order follows public statements by several Spanish pharmacists and a 400 member association of Catholic pharmacists, saying that they will not supply levonorgestrel because of ethical objections.

Spanish bishops have been asking doctors and pharmacists to invoke a conscientious objection to emergency contraception. Spanish law permits doctors to refuse to carry out abortions, but medicines legislation compels pharmacists to dispense all prescribed medicines. Pharmacists have been reminded of this and warned by both the health ministry and the president of the General Council of Pharmaceutical Colleges, Pedro Capilla.
Xavier Bosch

Back to Top


Asda launches diabetes initiative

Asda Pharmacy is to run an in-store disease-led marketing campaign during diabetes week (June 10 to 16).

In-store announcements will be made telling customers that it is diabetes week and suggesting that they get advice from the store pharmacist about the condition. Leaflets giving information on food and drink, and other products that are more suitable for people with diabetes, will be available. In addition, some stores are to hold booked shop tours, led by dietitians, which will be used to show people what foods are better for them and to emphasise the importance of eating five portions of fruit or vegetables a day.

Jeremy Armes, pharmacy buyer for Asda said: “In the United Sates, Wal-Mart does this sort of thing a great deal. It’s about getting our pharmacists recognised as a reputable source of information.”

Asda believes that diabetes patients are important customers. This is because US figures show th these customers spend 10 times more on health care than the average patient. Also, they tend to shop from predetermined lists, which makes them loyal customers.

Mr Armes added that Asda had been successful in selling Roche blood glucose meters and that this had had the knock-on effect of increasing turnover of insulin prescriptions by 300 per cent.

Back to Top


Boots increases emphasis on health and beauty

Boots The Chemists Ltd plans to boost sales of health and beauty products and services through its stores with new retail formats, including an upmarket Pure Beauty concept. Health and beauty products were the company’s star in the year to March 31, 2001, increasing 2.1 per cent on a like-for-like basis while total sales rose only 0.3 per cent to £3.99bn (down 0.2 per cent like-for-like).

Trials of the Pure Beauty concept will take place at eight stores in prime city centre locations. The first will open at Covent Garden, London, in September. Boots is to spend £14m opening the stores. They will stock premium beauty and toiletry products.

Boots is also revising the retail formats for its core pharmacy chain. A smaller number of standardised formats are to be piloted at 20 stores with the aim of reducing complexity and driving sales at a cost of £5m.

Wellbeing services — opticians, laser eye surgery, hearing aids, dental and chiropody — are to be expanded with up to 150 hearing aid centres, 200 dental, 200 chiropody and 12 health and beauty experience centres planned. The first Wellbeing centre, including a fitness suite and swimming pool, is to be opened at Greenford, West London, in the autumn. Both the Boots The Chemists and the Wellbeing divisions are to be managed as part of a single Boots UK and Ireland operation under managing director Ken Piggott.

During the year 16 more edge-of-town stores were opened, bringing the number to 70.

Commenting on resale price maintenance, Boots Co chief executive Steve Russell said: “We were well prepared for the abolition of RPM on over-the-counter medicines. We are responding vigorously to competitive activity and expect to increase market share in the medium term. In the short term, abolition is expected to reduce Boots The Chemists profits in a full year by between £15m and £20m.”

The Boots Co reported that total group sales rose by 0.7 per cent to £5.23bn. Pre-tax profits fell by 12.4 per cent to £492m due to costs of organisational restructuring and losses incurred by the Wellbeing, internet and Boots Retail International divisions.

n Boots is to open travel health clinics at its five health and beauty services stores. Customers will be able to obtain personalised information on diseases, political unrest, food an drink specific to their intended destinations. Vaccinations will also be available. The service is to be provided in conjunction with Medical Advisory Service for Travellers Abroad.

Boots has fallen behind Tesco in sales of non-prescription medicines, according to a report in the Observer on June 3. Boots fell behind Tesco in sales of toiletries last month.

Back to Top


Wholesalers to continue European expansion

Alliance Unichem Plc and Gehe AG have continued their European expansion drives with further acquisitions in Italy and Norway.

Alliance Unichem has acquired a 72 per cent stake in a group of six pharmacies owned by the municipality of Lucca, near Pisa in northern Italy, bringing its total number of pharmacies in Italy to 14.

Gehe AG has bought 98 per cent of Norsk Medisinaldepot ASA (NMD), the largest pharmaceutical wholesaler in Norway. Gehe has acquired 30 pharmacies in Norway since pharmacy ownership was deregulated on March 1.

Back to Top


Roche to shut UK R&D site

F Hoffman-La Roche Ltd is to close its pharmaceutical research and development and manufacturing operations at Welwyn Garden City, Hertfordshire, with the loss of around 700 jobs.

The closure is part of a world-wide restructuring of Roche’s pharmaceuticals division which will see up to 3,000 jobs lost over the next three years. Roche says that it has significant overcapacity in manufacturing as a result of changes to its product portfolio. It has decided to cease pharmaceutical manufacturing at Welwyn Garden City and chemical production at Basel, Switzerland.

Back to Top


SSL forced to restate profits

SSL International Plc, owner of the Durex, Scholl and Regent Biogel brands, has been forced to restate its trading figures for 2000 after an investigation found that both sales and profits had been overstated because of advance purchasing by customers. The company now has a new chief executive and finance director.

SSL reported sales of £649m and pre-tax profits of £91m for the year to March 31, 2001. The company said that comparisons with the previous year were complex because of a change in accounting date, acquisitions and trade loading (forward buying of products by customers). A decision to end trade loading and a subsequent investigation revealed that sales in the 25 months to March 31, 2000, had been overstated by £22m and profits by £19m. SSL’s customers were shown to be holding £63m of trade stock in excess of normal commercial levels, £36m of which was in the United Kingdom. Eliminating this excess stock will cost the company around £50m in profits in the current financial year.

The company says that sales of its recently launched Scholl Flight Socks, for preventing deep vein thrombosis in long-haul air travellers, have exceeded expectations.

Back to Top



©The Pharmaceutical Journal